Tilray Brands (NASDAQ:TLRY) Issues Earnings Results

Tilray Brands (NASDAQ:TLRY) released its quarterly earnings results on Thursday. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.16, FiscalAI reports. The business had revenue of $257.15 million for the quarter, compared to the consensus estimate of $266.26 million. Tilray Brands had a negative net margin of 13.11% and a negative return on equity of 7.76%.

Tilray Brands Stock Down 1.9%

TLRY stock opened at $3.71 on Thursday. The company has a market capitalization of $505.30 million, a P/E ratio of -3.44 and a beta of 1.91. Tilray Brands has a 12 month low of $3.54 and a 12 month high of $23.20. The firm’s fifty day simple moving average is $4.32 and its 200-day simple moving average is $5.05. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.21 and a quick ratio of 1.37.

More Tilray Brands News

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Tilray reported record first-quarter revenue of $257 million, up 23% year over year, while gross margin expanded by approximately 300 basis points to 30%. International cannabis, beverage and pharmaceutical distribution all posted double-digit growth, with EMEA revenue increasing 71%. Tilray Brands Q1 fiscal 2027 results
• Positive Sentiment: Adjusted earnings per share were a loss of $0.02, substantially better than the $0.18 loss analysts expected. Tilray also reaffirmed fiscal 2027 adjusted EBITDA guidance of $68 million to $75 million, reducing uncertainty around its outlook. Tilray Brands earnings coverage
• Positive Sentiment: The company reduced outstanding debt by $42 million during the fiscal year and ended the quarter with a net cash position. Its beverage business generated $101 million in revenue at a 41% gross margin, while BrewDog reached profitability in the quarter. Tilray balance sheet and segment results
• Positive Sentiment: BrewDog reported stronger retail momentum, new distribution points and eight additional on-trade partnerships. Its products also received recognition at the Scottish Beer Awards, supporting Tilray’s strategy of diversifying beyond cannabis. BrewDog Scottish Beer Awards announcement
• Neutral Sentiment: Tilray’s $257.15 million revenue exceeded the prior year but fell short of the $266.26 million consensus estimate. The company remains unprofitable, with a negative net margin of 13.11%, so investors will focus on whether revenue growth translates into sustained cash-flow improvement.
• Negative Sentiment: TD lowered its price target to C$6.50, although it maintained a Buy rating. The target reduction, combined with Tilray’s prolonged downtrend and highly volatile trading history, may limit investor confidence despite the earnings beat. TD price target reduction

Insiders Place Their Bets

In other news, CFO Carl Merton bought 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 4th. The stock was purchased at an average cost of $4.62 per share, for a total transaction of $46,200.00. Following the purchase, the chief financial officer directly owned 139,753 shares in the company, valued at approximately $645,658.86. This trade represents a 7.71% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased 15,000 shares of company stock worth $69,225 in the last three months. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on TLRY shares. Zacks Research lowered Tilray Brands from a “hold” rating to a “strong sell” rating in a research note on Tuesday, September 29th. TD Securities upgraded Tilray Brands to a “strong-buy” rating in a research report on Friday, July 31st. TD Cowen reduced their price target on Tilray Brands from $7.00 to $5.00 and set a “buy” rating for the company in a research report on Tuesday, July 14th. Wall Street Zen downgraded Tilray Brands from a “hold” rating to a “sell” rating in a research note on Saturday, August 1st. Finally, TD lowered their price objective on Tilray Brands from $4.70 to $4.50 and set a “buy” rating on the stock in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Tilray Brands has an average rating of “Hold” and an average target price of $6.38.

Tilray Brands Company Profile

Tilray Brands, Inc is a global consumer packaged goods company focused on cannabis, beverage alcohol, wellness and consumer products. The company develops, produces, distributes and markets a range of cannabis products, including dried flower, pre-rolls, vapes, edibles and medical cannabis products, subject to applicable regulations in the markets it serves.

Tilray also operates beverage alcohol businesses, including craft beer, spirits and other alcoholic beverages. Its portfolio has included brands such as SweetWater Brewing Company, Montauk Brewing Company and Breckenridge Distillery.